Oxyntomodulin vs Efinopegdutide

Head-to-head comparison of Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) and Efinopegdutide (Efinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyOxyntomodulinEfinopegdutide
CategoryWeight ManagementWeight Management
Full NameEndogenous glucagon-like peptide 1 and glucagon co-agonist peptideEfinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist
Molecular Weight~4,200 DaN/A
Half-Life12-15 minutesApproximately 1 week
Amino Acids37N/A
Typical DoseResearch doses vary; commonly 100-300 mcg in small human studiesTrial-dependent; weekly SC dosing
RouteSubcutaneous/IVSubcutaneous
Purity≥98%≥98%
Studies Count8014
Research StatusClinicalClinical

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

Efinopegdutide Benefits

  • reduced body weight
  • improved insulin sensitivity
  • reduced liver fat
  • greater satiety

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

Efinopegdutide Dosing

once-weekly subcutaneous injection|dose escalation during lead-in|maintenance dosing in trials

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

Efinopegdutide Side Effects

  • nausea
  • decreased appetite
  • fatigue

Research Overview

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

Efinopegdutide

Human trials have shown meaningful weight loss and improvements in hepatic steatosis biomarkers. It remains a research compound with ongoing development in metabolic disease.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Oxyntomodulin stacks with:

calorie-deficitresistance-training

Efinopegdutide stacks with:

metforminorlistat
GLP-1glucagon-coagonistendogenous-peptideappetite-regulationglp1glucagondual-agonistobesitynash